Lymphoma Trials Office: Clinical Trials

10 trials sponsored by Lymphoma Trials Office, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 4 completed, 1 terminated. 8 Phase 3, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 4, Unknown 3, Terminated 1
Phase 12Unknown 2
Phase 21Unknown 1

Follow Lymphoma Trials Office: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
bleomycin sulfate, filgrastim, pegfilgrastim - Lymphoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC5522002-08-012025-08-05
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
bleomycin sulfate, rituximab, prednisolone - Lymphoma
Phase 1UnknownLymphoma Trials Office2001-10-012013-09-20
Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
bleomycin sulfate, filgrastim, cyclophosphamide - Lymphoma
Phase 1 / Phase 2UnknownLymphoma Trials Office302001-10-012013-09-20
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma
chlorambucil, dexamethasone, fludarabine phosphate - Lymphoma
Phase 3UnknownLymphoma Trials Office5002000-05-012013-09-20
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
filgrastim, rituximab, carmustine - Lymphoma
Phase 3CompletedEBMT Solid Tumors Working Party4601999-10-012013-09-17
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
rituximab, CHOP regimen, cyclophosphamide - Lymphoma
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC4751999-05-012021-02-15
Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
bleomycin sulfate, CHOP regimen, cyclophosphamide - Lymphoma
Phase 3CompletedLymphoma Trials Office3101998-01-012013-06-26
Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
filgrastim, recombinant interferon alfa, cyclophosphamide - Lymphoma
Phase 3TerminatedEuropean Organisation for Research and Treatment of Cancer - EORTC4691997-03-012012-07-02
Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
chlorambucil, clarithromycin, omeprazole - Gastric Cancer
Phase 3UnknownLymphoma Trials Office2001995-03-012013-09-20
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
CHOP regimen, carmustine, cyclophosphamide - Lymphoma
Phase 3UnknownLymphoma Trials Office5001993-01-012013-09-20

Conditions studied

Lymphoma (9)  ·  Lymphoma, Follicular (6)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Large-Cell, Immunoblastic (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Hodgkin Disease (1)  ·  Stomach Neoplasms (1)

Interventions

Cyclophosphamide (7)  ·  Vincristine (7)  ·  Etoposide (5)  ·  Bleomycin (4)  ·  Doxorubicin (4)  ·  Filgrastim (4)  ·  Prednisone (4)  ·  Mitoxantrone (3)  ·  Peripheral Blood Stem Cell Transplantation (3)  ·  Prednisolone (3)  ·  Rituximab (3)  ·  VAP-cyclo protocol (3)  ·  Carmustine (2)  ·  Chlorambucil (2)  ·  Cytarabine (2)

Countries

United Kingdom (10)  ·  Poland (4)  ·  Australia (3)  ·  Belgium (3)  ·  Canada (3)  ·  Czechia (3)  ·  Denmark (3)  ·  France (3)  ·  Netherlands (3)  ·  New Zealand (3)  ·  Sweden (3)  ·  Hungary (2)  ·  Norway (2)  ·  Portugal (2)  ·  South Africa (2)

Top investigators

Ruth Pettengell, MD (4)  ·  David C. Linch (3)  ·  Robert Marcus, MD (2)  ·  Andy Haynes, MD (1)  ·  Anna Sureda (1)  ·  Anton Hagenbeek, MD, PhD (1)  ·  Barry W. Hancock, MD (1)  ·  Bengt Glimelius, MD (1)  ·  David Ma, MD (1)  ·  Devinder Gill, MD (1)  ·  Eva K. Kimby, MD, PhD (1)  ·  Marine Divine, MD (1)  ·  Max M. Wolf, MD (1)  ·  Patrice P. Carde, MD (1)

Results publications

PMID 11895791, PMID 16873669, PMID 19036078, PMID 20368567, PMID 20439641, PMID 23547078, PMID 27114593, PMID 34384709

NIH funding

2004 (1)